-
68 pharmaceutical listed companies after the first quarter of the pk, who is the big winner
Time of Update: 2020-06-16
Pharmaceutical Network Industry Dynamics: At present, the first quarter 2020 performance report of pharmaceutical listed companies has basically been released According to GPLP Rhino financial statis
-
Inner Mongolia's April drug and consumable sales top 10 list released
Time of Update: 2020-06-06
Medicines Network June 1 According to the Inner Mongolia Pharmaceutical Procurement Center statistics, in April 2020, the Inner Mongolia Autonomous Region pharmaceutical and medical supplies (includ
-
Tianmu Pharmaceuticals' illegal loan guarantee is regulated Net profit 10 years cumulative loss of 163 million debt ratio rose to 82
Time of Update: 2020-06-01
Recently, a paper administrative supervision measures of the Zhejiang Securities Regulatory Bureau decided, the Tianmu Pharmaceutical Sansie's internal control crisis once again thrust into the public
-
China exposes 14 serious illegal ads
Time of Update: 2020-05-13
BEIJING, April 15 (Reporter Liu Changzhong) China's State Administration for Industry and Commerce on the 15th exposed 14 cases of medical, health food and other serious illegal advertising The State
-
Wang Qiang points out the exploration of a new national system of Chinese medicine research and development system
Time of Update: 2020-05-13
On October 25, the First Western Forum on Chinese Medicine and the Founding Conference of the Chinese Academy of Traditional Chinese Medicine Resources Credit Stakes were held in Guiyang City, Guizho
-
Policy push to speed up the elimination of the knockout, a number of pharmaceutical companies to stop the development of generic drugs
Time of Update: 2020-05-06
Recently, the State Drug Administration has continuously issued the 25th and 26th batch of generic drug reference preparations, involving 177 varieties and 343 product regulations The industry believ
-
Chuanshegan flavone capsule, a new Chinese medicine of Fengchun pharmaceutical, has obtained the production approval and new drug certificate
Time of Update: 2020-04-03
Recently, Sichuan Fengchun Pharmaceutical Co., Ltd applied for chuanshegan flavone capsule, a new Chinese medicine, which has been approved for production and marketing after Sichuan Kangding Jinzhu P
-
Three specifications of irbesartan hydrochlorothiazide tablets of Huahai Pharmaceutical Co., Ltd. have been approved by FDA for listing
Time of Update: 2020-04-03
In the evening of May 12, Huahai pharmaceutical announced that the company's three specifications of irbesartan hydrochlorothiazide tablets were approved by FDA for listing Irbesartan hydrochlorothiaz
-
The growth rate of imitation application slows down, the Yangtze River has the most applications, and the levansaban is the hottest
Time of Update: 2020-01-28
In 2019, CDE undertook 1051 copy applications, with the growth rate slowing down Yangzijiang Pharmaceutical Group has the largest number of applied varieties, and Zhengda Tianqing has reduced by nearl
-
Seizing the blue ocean of the market, the technical level of traditional Chinese medicine production equipment still needs to be improved
Time of Update: 2019-12-21
[pharmaceutical network market analysis] in recent years, with the support of many favorable policies, China's traditional Chinese medicine industry has ushered in a good development opportunity, and
-
As low as 1:23! Announcement of the results of the central selection of 13 drugs in Hebei Province
Time of Update: 2019-12-21
[industry trends of pharmaceutical network] on December 19, Hebei medical drug and device Centralized Procurement Center released the list of 13 selected drugs for centralized procurement of outpatien
-
Huahai and Jointown have jointly sold 900 million irbesartan tablets and the off-standard market is being squeezed again
Time of Update: 2019-11-27
On November 26, Jiuzhoutong issued a notice that Jiuzhoutong and Huahai pharmaceutical, the holding subsidiary of Huahai pharmaceutical, signed the strategic cooperation framework agreement on Novembe
-
The national health insurance bureau starts a new round of negotiations! 50% PD-1 price reduction for the existing products, xiumeile, etc
Time of Update: 2019-11-12
On November 11, according to the associated press, the National Health Insurance Bureau launched a new round of negotiations on the access of Medicare drugs this week Before that, the health insurance
-
Consistency evaluation "counter attack"? 25 over 100 million products dongyangyao, xinlitai, qilufili
Time of Update: 2019-10-24
Since December 2014, Shanghai Pharmaceutical Institute has carried out three batches of centralized drug volume procurement Among them, the first batch has 3 varieties, the second batch and the third
-
Wacker US gas phase silicon dioxide plant put into operation
Time of Update: 2019-10-15
Recently, Wacker, a German chemical group, officially put into operation its fumed silica production plant in Charleston, Tennessee The annual capacity of the plant is 13000 tons The products are not
